MJXClass I
Kit, Serological, Positive Control
21 CFR 862.1660 / Clinical Chemistry
MJX is the FDA product code for Kit, Serological, Positive Control, a class I device type, regulated under 21 CFR 862.1660. As of , FDA records hold 7 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- MJX
- Device name
- Kit, Serological, Positive Control
- Regulation
- 21 CFR 862.1660
- Device class
- Class I
- Review panel
- Clinical Chemistry
- Submission type
- 510(k) exempt
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 7
- Ingested recalls
- 1
Clearances, product code MJX
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 1993 | 1 |
| 1994 | 1 |
| 1997 | 3 |
| 2003 | 1 |
| 2010 | 1 |
Applicants with the most clearances
Product code MJX| Applicant | Clearances |
|---|---|
| Aalto Scientific Ltd. | 1 |
| Boston Biomedica, Inc. | 1 |
| Ortho-Clinical Diagnostics, Inc. | 1 |
| Pb Diagnostic Systems, Inc. | 1 |
| Pb Diagnostics, Inc. | 1 |
| Scantibodies Laboratory Inc. | 1 |
| Simplicity Diagnostics, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
